Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Exscientia logo

Exscientia

Recent Finacing

Series D

Recent Raise

$225M

Exscientia operates AI-driven drug discovery platforms (Centaur Chemist, Centaur Biologist) that identify targets, design and prioritize small-molecule candidates and advance programs through preclinical and clinical development.

Founded 2012
Oxfordshire, United Kingdom
251-500
Publicly Traded
exscientia.ai

Highlights

Focus Areas

Artificial Intelligence (AI)
Biotechnology
Health Care
Pharmaceutical

Recent Investors

GT Healthcare Capital Partners logo
Evotec logo
Novo Holdings logo
Bristol Myers Squibb logo
BlackRock logo
Marshall Wace logo
Mubadala Investment Company logo
Pivotal bioVenture Partners logo
Farallon Capital Management logo
H
S
Exscientia logo

Financials

$432.8M

Total Raised

6

Funding rounds

16

Investors


Team

Upgrade to view the team

See the team members at Exscientia.